CHMG vs DBL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CHMG presents a dichotomy between strong growth fundamentals and bearish internal signals. The Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the stock trades slightly below its Graham Number ($61.29) and significantly below its growth-based intrinsic value ($92.63). While YoY earnings growth is impressive at 26.6% and the forward P/E of 7.90 suggests deep value, the combination of a 0/100 technical trend and consistent insider selling creates a cautionary environment.
DBL exhibits severe financial distress indicators, headlined by a critical Piotroski F-Score of 1/9, signaling weak fundamental health. The asset is currently trading at a significant premium to its intrinsic value of $7.56, while the 122.22% dividend payout ratio indicates an unsustainable yield that likely erodes capital. With a 0/100 technical trend and zero reported operating margins, the fund appears to be a value trap. The combination of poor health scores and overvaluation suggests a high risk of price correction.
Compare Another Pair
Related Comparisons
CHMG vs DBL: Head-to-Head Comparison
This page compares Chemung Financial Corporation (CHMG) and DoubleLine Opportunistic Credit Fund (DBL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.